Treatments
Programme
Results
Experts
Resources
menu-close
WHAT WE TREAT
Weight loss
Weight loss
icon
Menopause
Menopause
icon
ACCOUNT
Log in
icon
OVERVIEW
Weight loss overview
Weight loss overview
icon
TREATMENTS
Explore all options
Explore all options
icon
Mounjaro
Mounjaro
Lose up to 23% body weight
icon
Wegovy
Wegovy
Lose up to 21% body weight
icon
Saxenda
Saxenda
Lose up to 10% body weight
icon
Orlos
Orlos
Lose up to 8% body weight
icon
PROGRAMME
How it works
How it works
icon
Coaching
Coaching
icon
App
App
icon
ABOUT
Results
icon
Experts
icon
RESOURCES
Guides & tips
icon
ACCOUNT
Log in
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
OUR CLINIC
Menopause overview
Menopause overview
icon
Pricing
icon
Clinicians
icon
TREATMENT PLANS
Hormone replacement therapy
icon
Testosterone treatment
icon
Cognitive behavioural therapy
icon
Vaginal treatments
icon
BLOOD TESTS
Women's midlife (MOT) blood test
icon
Monitor HRT blood test
icon
Start testosterone blood test
icon
WHAT WE TREAT
Skincare
New
icon
Perimenopause
icon
Menopause
icon
Sexual health
icon
Weight management
icon
LEARN
Guides
icon
Treatments
icon
ACCOUNT
Log in
icon
SUPPORT
FAQ
icon
Home/Guides & Tips/Weight loss/

Wegovy benefits

Wegovy benefits: 6 ways it improves health beyond weight loss

Wegovy can work brilliantly for weight loss, but there are other health benefits of this medication you might not be aware of.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconPublished 22nd October 2025
Research-Based Guide
Table of contents
  • Wegovy could improve heart hea...
  • Wegovy helps keep blood sugar ...
  • Wegovy could reduce kidney ris...
  • Wegovy might improve PCOS symp...
  • Could Wegovy prevent Alzheimer...
  • Wegovy might help treat addict...
  • Wegovy vs Mounjaro: Where Wego...
  • Wegovy vs Ozempic: What’s the ...
  • Your weight loss journey

You may already know that Wegovy is highly effective for weight loss. In fact, the new maximum dose of 7.2 mg, which will be available soon in the UK, has been shown to achieve up to a 20.7% reduction in body weight.

But did you know that there’s actually a whole host of Wegovy health benefits beyond just shrinking your waistline? We’re talking heart protection to reproductive health—and researchers are even exploring its impact on complex conditions such as addiction and Alzheimer’s disease.

So, without further ado, let’s break down the benefits of Wegovy besides weight loss.

Wegovy could improve heart health and reduce stroke risk

Wegovy heart benefits are a great place to start. First up, getting to a healthy weight can improve blood pressure and cholesterol for everyone, while lowering levels of fat in the blood—all of which have cardiovascular benefits.

Plus, semaglutide (Wegovy’s active ingredient) has been shown to lower blood pressure and reduce the risk of serious heart problems like heart attack and stroke in people with type 2 diabetes.

Wegovy is currently the only GLP-1 medication licensed in the UK for this purpose among people who are overweight and/or have heart disease. Clinical trials found that participants taking semaglutide were 20% less likely to experience a stroke, heart attack, or further heart issues.

Discover Wegovy
Struggling to reach your target weight? You’re not alone. Find out about how medications like Wegovy can boost your efforts and get you closer to your health goals.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100,000 UK customers

Wegovy helps keep blood sugar under control

Wegovy helps keep blood sugar under control by stimulating insulin production and telling the liver to produce less glucose. This can help keep diabetes at bay, or, for those who have diabetes already, can help them manage it.

People who have diabetes either don’t produce enough insulin naturally, or are resistant to insulin’s effects, causing their blood sugar to become too high.

The weight loss brought about by Wegovy helps here, too. Since weight gain – specifically the inflammation it causes – can bring on insulin resistance as well.

Wegovy could reduce kidney risks

People with type 2 diabetes and chronic kidney disease (CKD) face a high risk of kidney failure.

A 2024 study tested whether semaglutide could help reduce kidney risks, alongside heart risks, in people with diabetes. Among 3,500 participants, semaglutide lowered the risk of major kidney problems by 24% compared with placebo, and slowed the decline in kidney function.

Wegovy might improve PCOS symptoms

Polycystic ovary syndrome (PCOS) is a hormonal condition that causes irregular periods, excess body hair and acne. It often goes hand-in-hand with insulin resistance. Together, the hormone imbalance and insulin issues make it easy to gain weight.

It can turn into a cycle: the weight gain exacerbates insulin resistance, so the body makes more insulin. But that extra insulin raises disrupts hormone balance even more, contributing to further weight gain—and aggravating PCOS symptoms like acne, hair loss, and irregular periods.

Because Wegovy helps regulate insulin and targets weight loss, it can help break that cycle.

In a 2023 study, people with PCOS and a BMI of 30+ took semaglutide for six months and lost an average of 11.5 kg, and most saw their menstrual cycles become regular again. Even losing just 5% body weight has been shown to reduce PCOS symptoms.

Could Wegovy prevent Alzheimer’s?

If we become resistant to insulin, we become less responsive to the messages that insulin sends to the brain. This can reduce the brain’s ability to get the energy it needs and function properly—and, in some people, can eventually develop into dementia.

By helping regulate insulin and blood sugar in the body, it’s thought that a medication like Wegovy might help protect the brain. A 2024 study supports this: Using health records from over a million patients with diabetes, researchers found that people taking semaglutide had a lower risk of being diagnosed with Alzheimer’s disease than those treated with insulin or other GLP-1 medications.

In animal studies, semaglutide has been shown to reduce harmful plaque buildup in the brain and calm neuroinflammation, both of which can contribute to Alzheimer’s.

Semaglutide is currently being studied as a potential treatment for early Alzheimer's.

Wegovy might help treat addiction

People taking semaglutide have said they have less “food noise”, AKA a constant and distracting habit of thinking about food. This isn’t an addiction per se, but the impact here has suggested that Wegovy could be helpful in managing addictive behaviours.

In a recent study of people with an alcohol use disorder, researchers found that semaglutide led to significantly fewer alcohol cravings and a reduction in alcohol consumption over nine weeks. In a smaller group of participants who smoked, semaglutide helped them cut down on cigarettes as well.

Researchers are now considering whether semaglutide could be used to treat alcohol use disorder.

Wegovy vs Mounjaro: Where Wegovy may be preferable

If you’re on a weight loss journey, you might be wondering about the benefits of Wegovy over Mounjaro. Let’s break it down.

  • Wegovy is more affordable. With Mounjaro’s recent price increase, Wegovy has become the more accessible option for a lot of people.
  • It offers comparable weight loss. As we mentioned, the higher Wegovy dose of 7.2 mg, coming soon to the UK, helped trial participants lose an average of 20.7% of their body weight, with about one in three losing 25% or more—close to the results seen with Mounjaro.
  • It’s the only GLP-1 licensed for heart protection. Wegovy is an approved medication for lowering the risk of major heart problems in people with obesity and heart disease in the UK. Mounjaro may have similar benefits, but it isn’t yet approved for this use in the UK.

Wegovy vs Ozempic: What’s the advantage?

Similarly, you might compare the benefits of Wegovy over Ozempic.

Wegovy and Ozempic share the same active ingredient (semaglutide), but they’re designed for different purposes. Ozempic is primarily a diabetes medication, with weight loss as a secondary benefit, while Wegovy is specifically approved for weight management.

Wegovy is also available at higher doses, and research shows that higher doses of semaglutide lead to better results. So it may be more effective for people looking to lose a significant amount of weight.

For a deeper dive on comparing the two, check out Voy’s guide to Wegovy vs. Ozempic.

Your weight loss journey

Ultimately, this isn’t just a medication for weight loss. The health benefits of Wegovy are notable, too: from heart health to brain protection and beyond. If you’re curious whether Wegovy could help you reach your health goals, find out in just a few minutes by taking Voy’s quick quiz.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

Wegovy benefits: FAQ

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Andreadis, Panagiotis, et al. “Semaglutide for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.” Diabetes, Obesity, and Metabolism, vol. 20, no. 9, 2018, pp. 2255–2263. doi.org/10.1111/dom.13361.

icon²

Carmina, Enrico, and Rosa Alba Longo. “Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs.” Journal of Clinical Medicine, vol. 12, no. 18, 2023, article no. 5921. doi.org/10.3390/jcm12185921.

icon³

Chuong, Vicky, et al. “The Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide Reduces Alcohol Drinking and Modulates Central GABA Neurotransmission.” JCI Insightscribble-underline, vol. 8, no. 12, 2023, e170671. https://doi.org/10.1172/jci.insight.170671.

icon⁴

Dumesic, Daniel A., et al. “Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.” Endocrine Reviewsscribble-underline, vol. 36, no. 5, 2015, pp. 487–525., https://doi.org/10.1210/er.2015-1018.

icon⁵

“Evoke: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects with Early Alzheimer's Disease.” ClinicalTrials.govscribble-underline, U.S. National Library of Medicine, https://clinicaltrials.gov/study/NCT04777396. Accessed 19 Oct. 2025.

icon⁶

Fatima, Nazeefa, et al. “Efficacy of Different Doses and Forms of the GLP-1 Receptor Agonist Semaglutide in Weight Reduction Among Non-Diabetic Obese or Overweight Populations.” Cureusscribble-underline, vol. 16, no. 9, 2024, e68786. https://doi.org/10.7759/cureus.68786.

icon⁷

Hendershot, Christian S., et al. “Once-Weekly Semaglutide in Adults with Alcohol Use Disorder: A Randomized Clinical Trial.” JAMA Psychiatryscribble-underline, vol. 82, no. 4, 2025, pp. 395–405. https://doi.org/10.1001/jamapsychiatry.2024.4789.

icon⁸

Husain, Mansoor, et al. “Semaglutide (SUSTAIN and PIONEER) Reduces Cardiovascular Events in Type 2 Diabetes across Varying Cardiovascular Risk.” Diabetes, Obesity, and Metabolism, vol. 22, no. 2, 2020, pp. 442–451. doi.org/10.1111/dom.13955.

icon⁹

Lincoff, A. Michael, et al. “Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.” The New England Journal of Medicine, vol. 389, no. 24, 2023, pp. 2221–2232. doi.org/10.1056/NEJMoa2307563

icon¹⁰

Meca, Andreea Daniela, et al. “Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models.” Current Issues in Molecular Biology, vol. 46, no. 6, 2024, pp. 5929–5949. doi.org/10.3390/cimb46060354.

icon¹¹

Muoio, Deborah M., and Christopher B. Newgard. “Molecular and Metabolic Mechanisms of Insulin Resistance and β-Cell Failure in Type 2 Diabetes.” Nature Reviews Molecular Cell Biology, vol. 9, 2008, pp. 193–205. doi.org/10.1038/nrm2327.

icon¹²

Perkovic, V., et al. “Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.” The New England Journal of Medicinescribble-underline, vol. 391, no. 2, 2024, pp. 109–121. doi.org/10.1056/NEJMoa2403347.

icon¹³

Purwar, Ananya, and Shailesh Nagpure. “Insulin Resistance in Polycystic Ovarian Syndrome.” Cureusscribble-underline, vol. 14, no. 10, 2022, e30351. doi:10.7759/cureus.30351.

icon¹⁴

Teede, H., et al. “Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive and Metabolic Manifestations That Impacts Health across the Lifespan.” BMC Medicine, vol. 8, 2010, article no. 41. doi.org/10.1186/1741-7015-8-41.

icon¹⁵

Wang, W., et al. “Associations of Semaglutide with First-Time Diagnosis of Alzheimer's Disease in Patients with Type 2 Diabetes: Target Trial Emulation Using Nationwide Real-World Data.” Alzheimer's & Dementiascribble-underline, vol. 20, no. 12, 2024, pp. 8661–8672. https://doi.org/10.1002/alz.14313.

icon¹⁶

Wharton, Sean, et al. “Effect of Semaglutide 7.2 mg on Anthropometric Measures of Obesity: The STEP UP Trial.” Novo Nordisk Science Hubscribble-underline, 15–19 Sept. 2025, Presentation, EASD/ADA 2025, sciencehub.novonordisk.com/congresses/ada2025/Wharton.html. Accessed 19 Oct. 2025.

icon¹⁷

Wilding, J. Philip H., et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicinescribble-underline, vol. 384, no. 11, 2021, pp. 989–1002. https://doi.org/10.1056/NEJMoa2032183.

Take the first step towards weight loss that lasts.

card-image
Weight loss
Mounjaro & digestive side effects
Starting Mounjaro or already on it and curious about side effects? You’re not alone. One of the most common questions people ask is what to expect in the first few weeks.
card-image
Weight loss
Still hungry on mounjaro?
If you’ve found Mounjaro isn’t curbing your appetite, don’t panic! Here’s what could be going on.
card-image
Weight Loss
Ozempic side effects: Is it safe?
Like all medicines, Ozempic can cause side effects, though they’re mild and manageable for most people. Here’s what you need to know.
Have a question?
phone icon
020 3912 9885Monday - Friday 9am - 5pm
support icon
help@joinvoy.comWe aim to reply in 24hrs
email icon
press@joinvoy.comPress & media inquiries
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999.

Programme

  • How it works
  • Treatments
  • Coaching
  • The Voy App

Voy

  • Medical experts
  • Results

Legal

  • Privacy policy
  • Terms & Conditions
  • Terms of Sale
  • Complaints

Get help

  • Help Centre (FAQ)
facebooktwitterinstagram
Copyright 2025 Voy. All rights reserved.
Pharmacies: Manual PharmacySuperintendent Pharmacist: Vinisha KandaGPhC Registration: 2203475
registered pharmacycqc ratingcpd member